Mahenthiran, Ajay
Wilcox, Jennifer
Tang, W.H. Wilson
Article History
Accepted: 10 January 2024
First Online: 1 February 2024
Declarations
:
: Dr. Tang has received consultancy fees from Sequana Medical, Cardiol Therapeutics, Genomics, Zehna Therapeutics, Boston Scientific, WhiteSwell, and Kiniksa Pharmaceuticals, CardiaTec Biosciences, Intellia Therapeutics, Bristol Myers Squibb, Alleviant Medical, and has received honorarium from Springer Nature, Belvoir Media Group, and American Board of Internal Medicine. Mr. Mahenthiran and Ms Wilcox have no relationships to disclose.
: This article does not contain any studies with human or animal subjects performed by any of the authors.